Indonesia Press Hits Archive


October 22, 2012-
The Star (Malaysia): Measure to make drugs affordable (links to thestar.com.my)

Kebijakan Kesehatan Indonesia

October 19, 2012-Al Jazeera (video): Indonesia allows local HIV drug production (links to aljazeera.com)

October 19, 2012-
The Jakarta Post: Drugs for HIV/AIDS, Hepatitis to be more affordable (links to thejakartapost.com)

October 18, 2012- Tech Dirt: After India, Indonesia Introduces Patent Licenses For Generic Versions of Drugs (links to techdirt.com)

European Business Chamber of Commerce in Indonesia

October 17, 2012-Tribun News: Obat ARV Generik Bagian dari Hak Asasi Manusia (links to tribunnews.com)

October 17, 2012- Managing IP: Indonesia targets seven drugs for compulsory licenses (links to managingip.com)

October 16, 2012-Pharm Asia: Indonesia issues CLs on seven foreign-made HIV/AIDS hepatitis B drugs (links to elsevierbi.com)

October 16, 2012- Human Rights LGBT Blog: Indonesia overrides patents on HIV drugs (links to humanrightslgbt.blogspot.com)

October 15, 2012-Pharm Asia: Indonesia takes compulsory licenses on foreign HIV/AIDS drugs (links to elsevierbi.com)

October 15, 2012
- Gay Star News: Indonesia overrides patents on HIV drugs (links to gaystarnews.com)

October 15, 2012-Pan Caribbean Partnership against HIV&AIDS (PANCAP): Indonesia issues compulsory licenses for generic ARVs (links to pancap.org)

October 15, 2012
- PM Live: Indonesia breaks seven HIV, hepatitis drug patents (links to pmlive.com)

October 15, 2012-PharmaAfrica: Indonesia issues compulsory licenses against seven HIV, hepatitis drugs (links to pharmaafrica.com)

October 15, 2012- Medical Patent News: Indonesia issues order to override patents on 7 HIV, hepatitis drugs (links to news-medical.net)

October 15, 2012-thepharmaletter: Indonesian government overrides patents on seven HIV and hepatitis drugs (links to thepharmaletter.com)

October 15, 2012
- Republika Online: Indonesia acts to override patents on HIV drugs (links to en.republika.co.id)

October 13, 2012- IP Komodo: The start of compulsory licenses in Indonesia (links to ipkomododragon.blogspot.hk)

October 13, 2012-European AIDS Treatment Group: Indonesia to override patents on HIV/hep B drugs (links to eatg.org)

October 12, 2012- Pharma Times: Indonesia to override patents on HIV/hep B drugs (links to pharmatimes.com)

October 12, 2012- EIN News: Indonesia issues compulsory licenses against seven HIV, hepatitis drugs (links to health.einnews.com)

October 12, 2012-Reuters: Indonesia acts to over-ride patents on HIV drugs (links to uk.reuters.com)

Jakarta Globe
CNBC

Chicago Tribune
MSNBC
FDA News
See other sites that posted the Reuters article

October 12, 2012- Info Justice: Public Citizen Press Release: Indonesia Licenses Patents for Seven HIV & Hepatitis B Medicines (links to infojustice.org)

October 12, 2012-IHS: Indonesia issues compulsory licenses against HIV, hepatitis drugs (links to ihs.com)

October 12, 2012- Kaiser--U.S. Global Health Policy: Indonesia Issues Order to Override Patents on 7 HIV, Hepatitis Drugs (links to globalhealth.kff.org)

October 12, 2012- Avert: Indonesia issues compulsory licenses for generic ARVs (links to avert.org)

October 12, 2012-Talk Vietnam: Indonesia acts to over-ride patents on HIV drugs (links to talkvietnam.com)

October 12, 2012-Tuoi tre news (Vietnam): Indonesia acts to over-ride patents on HIV drugs (links to tuoitrenews.vn)

October 12, 2012
-Designers Against AIDS: Indonesia Grants Rights For Companies to Manufacture Affordable Antiretroviral Medicines (links to designersagainstaids.com)

October 11, 2012- Poverty News Blog: Indonesia overrides all patents for HIV drugs (links to povertynewsblog.blogspot.com)

October 11, 2012
-Pharmalot: Indonesia Tries To Override Pharma Patents (links to pharmalot.com)

October 11, 2012-The Guardian: Indonesia in bold move to obtain cheap drugs for HIV (links to guardian.co.uk)

October 11, 2012-Foreign Exchange Translations: More challenges to drug patents in Asia (links to blog.fxtrans.com)

October 11, 2012- Y Charts: Pharma's March Into Emerging Markets Hits Yet Another Rough Spot (links to ycharts.com)

October 11, 2012-Grupo de trabalho sobre propriedade intelectual: Indonesia licencia Patentes para Sete Medicamentos de HIV e Hepatite B (in Portuguese) (links to deolhonaspatentes.org)

October 11, 2012-Fierce Pharma: Indonesia invites cheap copies of 7 patented HIV drugs (links to fiercepharma.com)

September 25, 2012
-Xinhuanet.com: Indonesia assures supply of drug for HIV/AIDs sufferer after donation cut (links to news.xinhuanet.com)

September 24, 2012-Jakarta Globe: Indonesia's HIV/AIDS Sufferers Call for Domestic Production of Drugs (links to thejakartaglobe.com)

September 20, 2012-Mindcomm Online: Pemegang Paten Obat Antiviral dan Antiretroviral Dapat Imbalan 0,5% Nilai Jual Netto (links to mindcommonline.com)

September 14, 2012-Sekretariat Kabinet Republik Indonesia: Pemerintah Perluas Paten Jenis Obat Anti HIV/AIDS dan Hepatitis B (links to sektab.go.id)

September 14, 2012-Politik Indonesia: Permerintah Perluas Paten Obat HIV/AIDS dan Hepatitis B (links to politikindonesia.com) (in Indonesian)

September 11, 2012-Jurnal Hukum Internasional: Compulsory License and Public Health Care in Indonesia (links to senandikahukum.com)

July 20, 2011-
Jakarta Globe: Concern in Indonesia Over Withdrawal of AIDS Drugs (links to thejakartaglobe.com)

October 28, 2010-The Jakarta Post: Indonesia's HIV/AIDS program at risk (links to thejakartapost.com)

November 26, 2007-Intellectual Property Watch: Indonesia Mulls Compulsory License On Three More HIV/AIDS Drugs (links to ip-watch.org)


Back to Indonesia Action Page

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.